Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Hans Hansen

Pain Medicine Conover, NC Medical Doctor

NPI 1750368197 CMS profile 170624

1224 Commerce St Sw, Conover, NC 28613

Open in the dashboard

General payments

$7,055

259 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Hans Hansen of Conover, NC is reported in the CMS Open Payments database as having received $7,055 across 259 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $122 2
2023 General $869 34
2022 General $554 14
2021 General $1,975 64
2020 General $1,158 33
2019 General $2,378 112

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hans Hansen
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Hans Hansen were reported at $0. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Hans Hansen Pain Medicine median Middle half National median
2019 $2,378 $506 $144–$1,566 $163
2020 $1,158 $315 $96–$934 $114
2021 $1,975 $452 $134–$1,237 $132
2022 $554 $475 $124–$1,407 $149
2023 $869 $480 $136–$1,384 $160
2024 $122 $521 $164–$1,511 $164
2025 $0 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Forte Bio-Pharma LLC $2,484 31 payments
  2. Collegium Pharmaceutical, Inc. $887 64 payments
  3. Abbott Laboratories $676 7 payments
  4. Boston Scientific Corporation $400 15 payments
  5. Daiichi Sankyo Inc. $273 13 payments
  6. Scilex Pharmaceuticals Inc. $254 18 payments
  7. Arbor Pharmaceuticals, Inc. $230 11 payments
  8. GRT US Holding, Inc. $192 4 payments
  9. Pfizer Inc. $165 11 payments
  10. Medtronic, Inc. $162 2 payments
  11. Other $1,332 83 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $7,055 259 payments
Products named General payments · program years 2019–2024
  1. NALOCET Pain $2,144 3 payments
  2. NALOCET Pain $1,089 29 payments
  3. XTAMPZA $887 64 payments
  4. PROLATE Pain $738 27 payments
  5. PROLATE Pain $738 27 payments
  6. PROLATE Pain $738 27 payments
  7. PROLATE Pain $738 27 payments
  8. PROLATE Pain $644 1 payment
  9. Prolate Pain $644 1 payment
  10. PROLATE Pain $644 1 payment
  11. Other $4,476 199 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

259 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record